用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
IRX THERAPEUTICS INC [US](3)
IRX THERAPEUTICS INC [US](2)
ABBOTT LAB(1)
HADDEN JOHN W [US](1)
Pfizer Products Inc.(1)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Muromonab'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
尾页
共
9
条记录, 当前第1/1页。
公开号
公开日
申请号
申请日
1.
US2014023593A1
2014/1/23
US201313940608
2013/7/12
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the s...
2.
NZ585702A
2013/8/30
NZ20080585702
2008/11/28
专利标题
:PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
专利权人
:
ABBOTT LAB
;
585702 Disclosed herein are aqueous formulations comprising water and at least about 20 mg/mL of an antibody, or antigen-binding fragment thereof, wherein the antibody, or antigen-binding fragment thereof, has a hydrodynamic diameter (Dh) which is at least about 50% less than the Dh of the antibody or had a hydrodynamic diameters of less than about 4 nm, or antigen-binding fragment thereof, in a buffered solution at the same concentration, and the antibody, or antigen-binding fragment thereof, h...
3.
EP2410334A1
2012/1/25
EP20110185960
2008/2/15
专利标题
:T-lymphocyte mitogen for use in a skin test
专利权人
:
IRX THERAPEUTICS INC [US]
;
The T lymphocyte is muromonab-CD3 for testing the effect of immunotherapy on a cancer patient in a skin test
4.
US2010047182A1
2010/2/25
US20080527288
2008/2/15
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the s...
5.
MX2009008690A
2009/9/4
MX20090008690
2009/8/13
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS.
专利权人
:
IRX THERAPEUTICS INC [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
6.
WO2008101154A2
2008/8/21
WO2008US54070
2008/2/15
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
HADDEN JOHN W [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
7.
CA2715529A1
2008/8/21
CA20082715529
2008/2/15
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
8.
ES2295495T3
2008/4/16
ES20030024332T
2000/11/23
专利标题
:Composiciones que contienen derivados de pirrolo (1,3-d)pirimidina.
专利权人
:
Pfizer Products Inc.
;
Una combinación que comprende uno o más agentes antiinflamatorios seleccionados del grupo que está constituido por ciclosporina A rapamicina tacrolimus leflunomida deoxispergualina micofenolato azatioprina daclizumab muromonab-CD3 (OKT3) globulina antitimocito (AtGam) aspirina acetaminofeno ibuprofeno naproxeno piroxicam prednisolona y dexametasona y un compuesto de la fórmula o la sal farmacéuticamente aceptable de la misma en la que R1 es un grupo de la fórmula en la que y es 0 1 ó 2; R4 se se...
9.
US2007154399A1
2007/7/5
US20070706946
2007/2/15
专利标题
:Immunotherapy for immune suppressed patients
专利权人
:
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the s...
首页
1
尾页
共
9
条记录, 当前第1/1页。
当前查询条件: [药品] 包含 'Muromonab'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文